Psychemedics Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 5.7 million compared to USD 6.52 million a year ago. Net loss was USD 2.1 million compared to USD 0.097 million a year ago. Diluted loss per share from continuing operations was USD 0.36 compared to USD 0.02 a year ago.
For the nine months, sales was USD 17.1 million compared to USD 19.54 million a year ago. Net loss was USD 3.21 million compared to USD 0.396 million a year ago. Diluted loss per share from continuing operations was USD 0.56 compared to USD 0.07 a year ago.